Literature DB >> 28936884

miR-218 suppresses epithelial-to-mesenchymal transition by targeting Robo1 and Ecop in lung adenocarcinoma cells.

Ying-Jie Li1, Wen Zhang1, Hui Xia1, Bao-Shi Zhang1, Ping Chen1, Yun-Long Zhao1, Jie Li2.   

Abstract

AIM: Although, miR-218 has been implicated in epithelial-to-mesenchymal transition process, the detailed mechanisms of miR-218 involvement in epithelial-to-mesenchymal transition in human lung adenocarcinoma cell are still unclear. MATERIALS &
METHODS: miR-218 function assays and its target gene analysis were performed.
RESULTS: miR-218 suppresses human lung adenocarcinoma cell migration and invasion and inhibits its target gene, Ecop and Robo1 expression, which subsequently suppresses NF-κB activity and its downstream targets.
CONCLUSION: miR-218 inhibits human lung adenocarcinoma cell migration and invasion via the suppression of Ecop and Robo1 expression, thus suggesting that miR-218 could serve as a potential therapeutic target.

Entities:  

Keywords:  EMT; Ecop; Robo1; epithelial-to-mesenchymal transition; lung adenocarcinoma; miR-218

Mesh:

Substances:

Year:  2017        PMID: 28936884     DOI: 10.2217/fon-2017-0398

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  5 in total

1.  Effects and mechanism of microRNA‑218 against lung cancer.

Authors:  Yan Chen; Ji-Lin Yang; Zhen-Zhen Xue; Qiu-Chen Cai; Chun Hou; Hong-Juan Li; Liu-Xin Zhao; Yin Zhang; Cheng-Wei Gao; Li Cong; Tian-Zuo Wang; Dong-Mei Chen; Guo-Sheng Li; Shi-Qing Luo; Qian Yao; Chan-Juan Yang; Qi-Shun Zhu; Chuan-Hai Cao
Journal:  Mol Med Rep       Date:  2020-11-12       Impact factor: 2.952

2.  RNA polymerase II subunit 3 regulates vesicular, overexpressed in cancer, prosurvival protein 1 expression to promote hepatocellular carcinoma.

Authors:  Peng Hu; Binfeng Wang; Ting Chen; Yongfu Xu; Guoqun Zheng; Yu Zhu; Xuefeng Du
Journal:  J Int Med Res       Date:  2021-04       Impact factor: 1.671

3.  miRNA‑218 targets multiple oncogenes and is a therapeutic target for osteosarcoma.

Authors:  Kentaro Sato; Eiji Osaka; Kyoko Fujiwara; Ryota Fujii; Tadateru Takayama; Yasuaki Tokuhashi; Kazuyoshi Nakanishi
Journal:  Oncol Rep       Date:  2022-03-16       Impact factor: 3.906

4.  Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker for Nasopharyngeal Carcinoma.

Authors:  Sung-Wei Lee; Ching-Chieh Yang; Hong-Yue Lai; Hsin-Hwa Tsai; Cheng-Fa Yeh; Yu-Hsuan Kuo; Nai-Wen Kang; Tzu-Ju Chen; Shih-Lun Chang
Journal:  Clin Med Insights Oncol       Date:  2022-07-22

5.  LncRNA LOXL1-AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR-423-5p and targeting MYBL2.

Authors:  Wei Li; Biao Zhang; Youchao Jia; Hongyun Shi; Haibo Wang; Qiang Guo; Hefei Li
Journal:  Cancer Med       Date:  2019-11-23       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.